USCB (USCB) EVP Logrono receives 15,000 restricted stock shares in Form 4

Rhea-AI Filing Summary

USCB Financial Holdings EVP and Chief Risk Officer Maricarmen Logrono received a grant of 15,000 shares of Class A Voting Common Stock as restricted stock on January 27, 2026. The award was granted at no cash cost and will vest in equal one-third installments each year starting on January 27, 2027.

After this grant, Logrono directly holds 30,892 shares of Class A Voting Common Stock, including previously granted restricted stock referenced in the footnotes. She also holds options to purchase 15,000 shares of Class A Voting Common Stock at an exercise price of $12.0500 per share, which vested in one-third annual installments beginning on September 27, 2021 and expire on September 27, 2031.

Insights

Equity compensation analyst

Executive received time-vested restricted stock; routine compensation, not a market trade.

The filing shows Maricarmen Logrono, EVP and Chief Risk Officer of USCB Financial Holdings, receiving 15,000 shares of restricted Class A Voting Common Stock as equity compensation. The shares vest in three equal annual tranches starting on January 27, 2027, supporting long-term retention.

This is a non-cash award at $0 per share, not an open-market purchase. Following the grant, she holds 30,892 common shares and options over 15,000 additional shares at an exercise price of $12.0500 expiring on September 27, 2031. The transaction is routine and does not, by itself, signal a change in outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Logrono Maricarmen

(Last) (First) (Middle)

C/O USCB FINANCIAL HOLDINGS, INC.

2301 N.W. 87TH AVENUE

(Street)

DORAL FLORIDA 33172

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
USCB FINANCIAL HOLDINGS, INC. [ USCB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief Risk Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Voting Common Stock	01/27/2026		A		15,000(1)	A	$0	30,892(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to Purchase Class A Voting Stock	$12.05							09/27/2022(3)	09/27/2031	Class A Voting Common Stock	15,000		15,000	D

Explanation of Responses:

1. Represents the grant of 15,000 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027.

2. Includes 876 shares of restricted stock from a grant of 2,630 shares which commenced vesting at a rate of one-third per year on January 22, 2025, 3,920 shares of restricted stock from a grant of 5,880 shares which commenced vesting at a rate of one-third per year on January 21, 2026 and 6,217 shares of restricted stock which vest at the rate of one-third per year commencing on January 27, 2027.

3. The options vested at a rate of one-third per year commencing on September 27, 2021.

	/s/ Robert Anderson by P.O.A. for Maricarmen Logrono	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did USCB EVP Maricarmen Logrono acquire in this Form 4 filing for USCB?

Maricarmen Logrono received a grant of 15,000 restricted shares of USCB Class A Voting Common Stock. The award is equity compensation, not a market purchase, and was issued at no cash cost per share on January 27, 2026.

How do the 15,000 restricted USCB shares granted to Maricarmen Logrono vest?

The 15,000 restricted USCB shares vest in three equal installments. One-third of the award vests each year, beginning on January 27, 2027, aligning the executive’s incentives with longer-term company performance over a multi-year period.

What are Maricarmen Logrono’s total direct USCB common share holdings after this Form 4?

After the restricted stock grant, Maricarmen Logrono directly holds 30,892 shares of USCB Class A Voting Common Stock. This total includes newly granted restricted shares and earlier restricted stock awards described in the accompanying footnotes.

What USCB stock options does Maricarmen Logrono hold according to this Form 4?

She holds options to purchase 15,000 shares of USCB Class A Voting Common Stock at an exercise price of $12.0500 per share. These options vested in one-third annual installments starting September 27, 2021 and expire on September 27, 2031.

Is the USCB Form 4 transaction for Maricarmen Logrono a stock sale or purchase on the market?

The transaction is an equity grant, not a market trade. Maricarmen Logrono received 15,000 restricted shares as compensation at $0.00 per share, so it does not represent an open-market buy or sell decision by the executive.

What do the Form 4 footnotes reveal about previous USCB restricted stock grants to Maricarmen Logrono?

The footnotes show she also holds restricted shares from prior grants of 2,630, 5,880, and 6,217 shares. These earlier awards vest at one-third per year starting January 22, 2025, January 21, 2026, and January 27, 2027, respectively.